Brief Summary
This discussion explores the latest advancements in longevity research, focusing on epigenetic reprogramming, gene therapy, and the development of accessible therapeutics. It highlights the potential for reversing aging and extending healthy human lifespans, while also addressing the challenges of funding scientific research and the importance of personal lifestyle choices.
- Epigenetic reprogramming shows promise in reversing aging in various tissues.
- New funding models are accelerating scientific research.
- Lifestyle choices significantly impact longevity.
The Dawn of Epigenetic Reprogramming
The discussion begins with an optimistic outlook on epigenetic reprogramming, comparing it to the Wright brothers' first flight. A drug candidate developed from David Sinclair's lab, based on the Yamanaka genes, is about to enter its first human trial to cure blindness. This technology aims to reverse aging safely without causing cancer or loss of cell identity.
Exploring the Potential of Longevity Therapeutics
The technology's potential extends beyond the eye, showing benefits in brain age reversal, memory improvement, motor neurons (ALS), the immune system, muscle, kidney, liver, skin, and joints. The goal is to develop a longevity therapeutic that works throughout the entire body. The current focus on individual tissues is due to FDA caution, but the aim is to eventually administer the therapy intravenously.
Innovations in Gene Therapy and Accessibility
Current gene therapies using adeno-associated viruses (AAV) are expensive, costing hundreds of thousands to millions of dollars per treatment. To address this, Sinclair's lab is developing a small molecule alternative that could potentially cost only a few cents per pill. This new technology uses artificial intelligence to screen billions of molecules, aiming to reverse aging in human cells.
The Future of Longevity: Cost and Accessibility
The goal is to make longevity therapeutics accessible to everyone, not just the wealthy. While current AAV gene therapies are costly, the small molecule cocktail under development aims for a price point similar to Metformin, making it affordable worldwide. Clinical trials for these molecules are expected to begin soon, with the hope of demonstrating age reversal in humans by 2026.
The Science of Aging: Limits and Possibilities
There is no known biological limit to how long humans can live. Animal studies show that living hundreds of years is possible, and the discovery of a cellular reboot system that can reset cells to a young state opens new possibilities. While living forever is not guaranteed, the advancements in the field suggest that significant lifespan extension is achievable.
Funding Science: A New Approach to Research
Traditional scientific funding models often hinder radical research due to their retrospective and risk-averse nature. The "Friends of Sinclair Lab" (Fossil) was created to provide direct funding to cutting-edge research, bypassing the slow and restrictive grant system. This model allows for faster progress and more innovative experiments, with members gaining personal relationships with scientists and early access to discoveries.
Personal Longevity Protocols and Lifestyle Choices
David Sinclair shares his personal longevity protocols, which include taking resveratrol (with olive oil or yogurt), NMN (nicotinamide mononucleotide), and either Metformin or berberine (to lower glucose levels). He also emphasizes the importance of monitoring glucose levels and avoiding processed carbs. Additional supplements include nattokinase to reverse plaque in the body. Lifestyle changes, inspired by his wife Serena, include a mostly vegan diet, reduced alcohol consumption, stress management through meditation, and maintaining strong social connections to combat loneliness.
